PVT1 is overexpressed, compared to healthy tissues, in breast and ovarian cancer, pediatric malignant astrocytomas, AML and Hodgkin lymphoma [171], suggesting that PVT1 could be an oncogene. This evidence concerns the gene PVT1 and ovarian carcinoma.